Biosearch

The UK-based firm plans to marry its core strengths with the probes and PCR platforms, and to build its sales force in the US. 

The acquisition will enable LGC to deliver product and laboratory service offerings for core qPCR and end-point PCR applications, as well as NGS. 

Co-Diagnostics will license its CoPrimers technology to Biosearch to make, use, market, and sell the primer-dimer-reducing oligonucleotides.

Mo Bio Laboratories has launched the PowerMag Blood DNA/RNA Isolation Kit.

NEW YORK (GenomeWeb) — ATCC has partnered with the US Centers for Disease Control and Prevention and Thermo Fisher Scientific's Life Technologies, among other organizations, to manufacture and distribute a rapid, cost-effective genotyping kit to monitor HIV-1 drug resistance in resource-limited c

NEW YORK (GenomeWeb News) – Biosearch Technologies today announced it has acquired the exclusive worldwide rights to the turboFISH technology.

The story has been updated to include comments by a Biosearch official about LightSpeed's next-gen sequencing development efforts.

Biocartis of Lausanne, Switzerland, has been awarded US Patent No. 8,441,629, "Optical detection system for monitoring rtPCR reaction."

NEW YORK (GenomeWeb News) – Biosearch Technologies today said that it has acquired the exclusive worldwide rights to continuing Stellaris RNA FISH-based inventions from the University of Medicine and Dentistry of New Jersey.

NEW YORK (GenomeWeb News) – Biosearch Technologies said today that it has acquired the oligonucleotide manufacturing division of DNA Technology for an undisclosed amount.

Pages

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.